Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,185 | 947 | 99.0% |
| Education | $141.45 | 8 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,589 | 96 | $0 (2024) |
| Novo Nordisk Inc | $1,213 | 106 | $0 (2024) |
| Lilly USA, LLC | $1,041 | 74 | $0 (2024) |
| ABBVIE INC. | $951.04 | 85 | $0 (2024) |
| Amgen Inc. | $772.62 | 53 | $0 (2024) |
| Corium, LLC | $679.49 | 28 | $0 (2024) |
| PFIZER INC. | $659.69 | 44 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $603.50 | 44 | $0 (2024) |
| GlaxoSmithKline, LLC. | $585.58 | 40 | $0 (2024) |
| Allergan, Inc. | $560.47 | 52 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,073 | 112 | Corium, LLC ($219.93) |
| 2023 | $2,267 | 136 | Corium, LLC ($289.89) |
| 2022 | $1,657 | 105 | Biohaven Pharmaceutical Holding Company Ltd. ($182.84) |
| 2021 | $2,215 | 164 | AbbVie Inc. ($364.60) |
| 2020 | $1,926 | 135 | AstraZeneca Pharmaceuticals LP ($320.27) |
| 2019 | $1,402 | 92 | AstraZeneca Pharmaceuticals LP ($326.23) |
| 2018 | $1,414 | 104 | AstraZeneca Pharmaceuticals LP ($297.37) |
| 2017 | $1,373 | 107 | Novo Nordisk Inc ($194.58) |
All Payment Transactions
955 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $22.39 | General |
| Category: Opioid Analgesic | ||||||
| 12/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Cardio-renal | ||||||
| 12/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.74 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.50 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Inflammation | ||||||
| 11/07/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/06/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Endocrinology | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/29/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $24.87 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | Lilly USA, LLC | ADCIRCA (Drug), MOUNJARO, ZEPBOUND | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Men's Health | ||||||
| 10/14/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Gastroenterology | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $34.82 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: PAIN | ||||||
| 09/30/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Endocrinology | ||||||
| 09/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Inflammation | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,582 | 4,142 | $494,142 | $145,028 |
| 2022 | 23 | 1,718 | 4,419 | $452,222 | $142,284 |
| 2021 | 23 | 2,015 | 5,537 | $389,480 | $172,588 |
| 2020 | 22 | 2,163 | 6,099 | $447,414 | $170,952 |
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 345 | 834 | $243,528 | $66,969 | 27.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 196 | 196 | $58,408 | $23,130 | 39.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 143 | 194 | $39,964 | $10,824 | 27.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 28 | 28 | $12,600 | $7,287 | 57.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 47 | 47 | $17,672 | $7,101 | 40.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 90 | 90 | $10,980 | $6,255 | 57.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 18 | 24 | $11,208 | $3,479 | 31.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 122 | 346 | $11,072 | $3,102 | 28.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 19 | 19 | $7,163 | $2,929 | 40.9% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2023 | 12 | 12 | $5,148 | $2,781 | 54.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 91 | 91 | $4,550 | $2,777 | 61.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 38 | 43 | $5,633 | $1,959 | 34.8% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 13 | 13 | $2,964 | $1,570 | 53.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 50 | 50 | $2,500 | $1,495 | 59.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 23 | 25 | $3,200 | $960.25 | 30.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $4,136 | $666.11 | 16.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 18 | 20 | $1,580 | $390.40 | 24.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 21 | 21 | $903.00 | $337.00 | 37.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 29 | 29 | $986.00 | $277.42 | 28.1% |
| 92228 | Imaging of retina with remote review by physician | Office | 2023 | 14 | 14 | $994.00 | $192.96 | 19.4% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 51 | 386 | $2,702 | $138.26 | 5.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 92 | 1,481 | $44,160 | $122.43 | 0.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 33 | 41 | $205.00 | $90.20 | 44.0% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 33 | 35 | $420.00 | $89.37 | 21.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 28 | 74 | $1,340 | $74.63 | 5.6% |
About Shannon Barton
Shannon Barton is a Family Medicine healthcare provider based in Monticello, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1295738722.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Shannon Barton has received a total of $14,327 in payments from pharmaceutical and medical device companies, with $2,073 received in 2024. These payments were reported across 955 transactions from 68 companies. The most common payment nature is "Food and Beverage" ($14,185).
As a Medicare-enrolled provider, Barton has provided services to 7,478 Medicare beneficiaries, totaling 20,197 services with total Medicare billing of $630,852. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Monticello, GA
- Active Since 05/30/2005
- Last Updated 05/16/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1295738722
Products in Payments
- FARXIGA (Drug) $1,355
- VRAYLAR (Drug) $759.24
- Ozempic (Drug) $533.91
- JARDIANCE (Drug) $488.07
- Azstarys (Drug) $480.75
- NURTEC ODT (Drug) $415.11
- MOUNJARO (Drug) $350.02
- TRELEGY ELLIPTA (Drug) $333.07
- Otezla (Drug) $329.64
- REXULTI (Drug) $323.31
- Aimovig (Biological) $303.24
- UBRELVY (Drug) $290.68
- ELIQUIS (Drug) $283.37
- Kerendia (Drug) $280.69
- INVOKANA (Drug) $264.82
- TRULICITY (Drug) $255.66
- SOLIQUA 100/33 (Biological) $238.41
- XARELTO (Drug) $225.75
- EMGALITY (Drug) $223.41
- Quillivant XR (Drug) $208.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Monticello
Dr. Jay Connelley, M.d, M.D
Family Medicine — Payments: $9,677
Dr. Timothy Simon, M.d, M.D
Family Medicine — Payments: $7,970
Dr. Joseph Fakouri, M.d, M.D
Family Medicine — Payments: $7,699
Abraham Garfinkel, M.d, M.D
Family Medicine — Payments: $6,672
Jeffrey Reinhart, Md, MD
Family Medicine — Payments: $6,624
Julia Nicholson, M.d, M.D
Family Medicine — Payments: $6,229